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In order to assess the incidence of HIV mixed infection as well as to clarify the molecular epidemiology of HIV in central
Africa, we investigated 43 HIVs obtained from 211 Cameroonian AC, ARC, and AIDS patients in 1994 and 1995. Part of the
pol region and part of the env region were phylogenetically analyzed. The genotypes observed were varied: of 43 specimens,
28 (65%) were subtype A, 1 (2%) was subtype B, 2 (5%) were subtype D, 3 (7%) were subtype F, and 2 (5%) were group O. Of
the remaining 7 specimens, 3 were mixed infections with HIV-1 subtypes A and C, HIV-1 subtypes C and F, and HIV-2 subtype
A and HIV-1 subtype A; 1 was a mixed infection with HIV-1 subtypes A and D and the highly divergent group O (triple
infection); another 3 appeared to consist of mosaic genomes (A/G, A/E, and B/A recombinant). These data show that various
types of mixed infection, such as between different subtypes of HIV-1 group M, between HIV-1 and HIV-2, and even between
HIV-1 groups O and M, were confirmed at a rather high frequency (approximately 10%). The mixed infection is particularly
significant where there is a greater variety of HIV-1 subtypes circulating, since it results in new genetic diversity generated
by intersubtype recombination. © 1998 Academic Press
INTRODUCTION
Recently much attention has been paid to the role of
mixed HIV infections in the evolution of HIV-1 and HIV-2,
because their resultant intersubtype recombination may
contribute substantially to the rapid emergence of HIV
variants. However, the evidence for co-infection or su-
perinfection has been rather rarely reported despite the
presence of a large population of individuals with re-
peated exposures via sexual contacts or the sharing of
contaminated needles. Several reports have so far doc-
umented mixed infection in an individual, including the
existence of HIV-1/HIV-2 dual infections (10), double in-
fection with two different subtypes of HIV-1 (2, 14), and
mixed infection of multiple strains of HIV-1 subtype B (29,
3). These cases were from rather limited areas, and so,
clearly, the study of mixed infection needs to be carried
out on a worldwide basis.
To date, all the putative intersubtype recombinants
appeared to have originated from areas where multiple
subtypes are cocirculating, such as central Africa, South
America, and Southeast Asia (19). In Cameroon, inde-
pendent studies have reported the presence of various
HIV-1 subtypes of group M (major) (20) as well as highly
divergent strains (MVP5180 and ANT70) of HIV-1 group O
(outlier) (11, 26, 12, 17). However, very little is known
about the HIV mixed infection in Cameroon. We thought
that this central African country would be suitable for
assessing its incidence. Here we report our findings that
mixed infection with various HIV-1 strains is not as rare
as previously thought.
RESULTS
Subjects and HIV serology
Of 211 patients that took part in our study, 68 (32%)
were HIV seropositive. Of these 68 patients, 60 (89%)
were HIV-1 positive, 3 (4%) were dual HIV-1/2 positive,
and 5 (7%) were indeterminate. None were positive for
only HIV-2. DNAs from 43 samples have remained avail-
able and were sequenced for molecular characterization
(Table 1). Epidemiological and clinical data relevant to
these samples are summarized in Table 2. (In this study,
CMRn refers to a HIV strain, where n is a number and
cmrn refers to the patient from which the strain was
obtained.)
The nucleotide sequence data reported in this paper were submitted
to GenBank nucleotide sequence database and the following acces-
sion numbers have been assigned: the pol sequences (288 bp), U58157,
U58158, U69207 to U69253, AF023085; the env sequences (approxi-
mately 390 bp), U58148, U58149, U58152, U58153, U69991 to U70014,
and AF023064 to AF023084.
1 To whom reprint requests should be addressed. Fax: 81-75-761-
9335. E-mail: mhayami@virus.kyoto-u.ac.jp.
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Phylogenetic analysis of the HIV-1 env region
To obtain a molecular epidemiological overview of HIV
in Cameroon, the central portion of gp120 including the
V3 region was sequenced, and a phylogenetic tree was
constructed (Fig. 1). The majority of HIV-1s in this country
belonged to subtype A (29 of 43 specimens, 67%), and
the rest belonged to various subtypes: 1 (2%) (CMR277)
belonged to subtype B, 2 (5%) (CMR68 and CMR370)
belonged to subtype D, 1 (2%) (CMR10) belonged to
subtype E, 3 (7%) (CMR158, CMR271, and CMR304) be-
longed to subtype F, and 1 (2%) (CMR276) belonged to
subtype G (Table 2 and Fig. 1). In addition, 2 strains (5%)
(CMR275-C and CMR281-C) belonged to subtype C,
whereas other strains from the same patients belonged
to different subtypes (F and A) (see the ‘‘Cases of mixed
infection . . .’’ described below). The sequences of sub-
types C, D, and G had not been previously reported in
Cameroon. There is no doubt that a large variety of HIV-1
subtypes, A through H (except I and J) plus group O, were
found in this country. (Subtype H was previously reported
in Cameroon (13).)
Figure 2 shows the deduced amino acid sequences
from all the analyzed nucleotide sequences in the env
region. For convenience of comparison, the results are
compiled according to each subtype. The V3 loop (cys-
teine to cysteine) of all the Cameroonian strains of sub-
type A were composed of 35 amino acid residues. This
observation is generally consistent with what has been
seen in the V3 loop sequences of all the other subtypes.
But CMR61-D and CMR68 (subtype D) and CMR304 (sub-
type F) had 34 amino acid residues, and CMR 10 (sub-
type E) had only 32 residues. On the other hand,
CMR61-O (group O) had two types of sequences: one
(CMR61-O clone 1) had 33 residues but the other
(CMR61-O clone 10) had 40 residues. We also found
unique tetrameric sequences at the tip of the loop. In
subtype A of the African strains, GPGQ was previously
shown to be a common tetrameric sequence (19). How-
ever, the sequence of CMR309 (subtype A) was GPGI
which has not been reported previously, even in other
subtypes. The sequences of CMR61-D and CMR370
(subtype D) were GPRQ and APGE, respectively, neither
of which had been reported even in other subtypes. In
addition, CMR10 (subtype E) also showed a unique tet-
rameric sequence, GLGH. Thus, remarkable heterogene-
ity was observed in the tetrameric sequences, but the
GPG (Gly-Pro-Gly) motif in the V3 loop appears to be
particularly dominant in Cameroonian HIV-1 group M
sequences.
Phylogenetic analysis of the pol region
Figure 3A shows a phylogenetic tree constructed from
the pol sequences. The 288-bp-long sequence amplified
with the integrase primers is considered sufficiently rep-
resentative of the whole pol gene (18). Unlike the env
analysis, by which at least 10 major HIV-1 subtypes (A
through J) have been described (19, 16, 1), the present
pol analysis revealed that HIV-1 fell into five major and
clearly defined subtypes: A, B, C, D, and F. The HIV-1
subtypes are genetically quite distinct, with nucleotide
distances of up to 18% in the pol (and 30% in the env) in
this study. In this pol tree, subtypes E and G were
included in subtype A. Neither subtype has been previ-
ously reported as far as the pol sequences are con-
cerned, and it is unknown whether they are really
present. Instead, we found a new cluster (subtype F) of
pol sequences that have not been described before.
Their clustering is well supported by the high value of the
bootstrap estimation. We consider that these pol se-
quences can be defined as subtype F, because both the
pol and corresponding env sequences were derived from
the same genome amplified by extra long (XL) PCR (data
not shown). Additionally, it is noted that CMR106 is the
first HIV-2 subtype A (HIV-2a) from a central African
country to be identified by sequencing (Fig. 3B). It is
likely that HIV-2 infection was introduced into this coun-
try in recent years (28).
Cases of mixed infection and suspected
recombination
To enhance the sensitivity of detection, we used a
different set of primers in addition to the standard prim-
ers (Table 1). Multiple sequences in the same genomic
region were found in four individuals: HIV-1 subtypes C
and F in cmr275, HIV-1 subtypes A and C in cmr281, HIV-1
group O and subtypes A and D in cmr61, and HIV-1
subtypes A and HIV-2 subtype A in cmr106 (Table 2, Figs.
1, 3A, and 3B). The coexistence of multiple sequences
was observed in both the pol and env regions in cmr275,
cmr281, and cmr61. (Confirmation of the existence of an
HIV-2 sequence in the env region was not done, since
two divergent sequences, HIV-1 and HIV-2, were con-
firmed in the pol analysis.) The presence of two or three
different sequences in each individual clearly demon-
strated that these are cases of dual infection or triple
infection with HIV strains of different origins. In addition
to the four above-mentioned clear cases of mixed infec-
tion, we also found two more highly probable cases of
double infection with two strains belonging to the same
subtype. One is cmr323, who had two types of subtype A
sequences (CMR323 clone 1 and CMR323 clone 4: 12%
divergence), with CMR105 (subtype A) located between
these two sequences on the env tree. The other is cmr68,
who had two types of subtype D sequences (CMR68
clone 3 (or clone 4) and CMR68 clone 11: 16% diver-
gence) (Figs. 1 and 2).
A comparison of the pol and the env sequences re-
vealed that most of the Cameroonian HIV-1s belonged to
the same subtypes, but some of them were different
(Figs. 1 and 3A). In this study, three HIV-1s (CMR276,
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FIG. 1. A phylogenetic tree of the HIV-1 env sequences. The tree was constructed from part of the env sequences including those in the V3 region
(approximately 390 bp). A few isolates belonging to group O and SIVcpzGAB (Gabon) were used as outgroups to root the tree. Subtypes are indicated
by brackets, and the Cameroonian specimens are boxed.
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FIG. 3. Phylogenetic trees of HIV-1 (A) and HIV-2 (B) based on part of the pol sequences (288 bp). The Cameroonian specimens are boxed. The
phylogenetic tree (A) included two Indian isolates of subtype C (D747 and D1044), kindly provided by Dr. H. Ru¨bsamen-Waigmann, Georg-Speyer-
Haus, Frankfurt am Main, Germany, and one Japanese isolate of subtype E (NH1), kindly provided by Dr. Y. Takebe, National Institute of Infectious
Diseases, Tokyo, Japan. The pol sequences of these isolates were determined in this study. In the HIV-2 lineages (B), subtypes C through F were not
included in this tree, because their reported sequences did not overlap with ours.
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CMR10, and CMR317) occupied different positions in two
phylogenetic trees. CMR276 belonged to subtype G by
its env sequence, whereas it was grouped into subtype A
by its pol sequence. CMR10 exhibited a subtype A pol
sequence in spite of its having a subtype E env se-
quence. CMR317 had an env sequence belonging to
subtype A and a pol sequence belonging to subtype B.
These three strains were suspected to be examples of
recombination (discussed below).
DISCUSSION
To investigate the incidence of mixed infection, it is
important to distinguish between mixed infection of a
patient with two or more genetically distinct HIV strains
and infection of a patient with an intersubtype recombi-
nant HIV strain. Mixed infection is indicated by the co-
existence of multiple sequences in a certain part of the
viral genome within one patient (29). Based on this def-
inition, it is clear that the four individuals who possessed
two or more different sequences in the pol analysis
(cmr275, cmr281, cmr61, and cmr106) were cases of
mixed infection. In addition, we also found two strains of
subtype A (cmr323) or subtype D (cmr68) in an individual.
These two cases may be due to double infection with
two different viruses, because the two sequences found
in each individual showed more than 10% divergence
without any strains occupying intermediate positions be-
tween the two distinct sequences. If we take into account
these two more highly probable cases, the total number
of mixed infections would increase to six.
On the other hand, recombination is detected when
different genes, or different regions, within the same
genome are placed by phylogenetic analysis into differ-
ent subtypes or as distant members of established sub-
types (21, 22, 6). By this definition, three subjects
(CMR276, CMR10, and CMR317) were suspected to be
cases of recombination. The result of CMR276 (subtype
A in the pol and subtype G in the env) can be explained
by an infection with an A/G recombinant. This was later
confirmed through the characterization of a long se-
quence from the pol region to env region using XL PCR
(manuscript in preparation). Likewise, the result of
CMR10 (subtype A in the pol and subtype E in the env)
can be interpreted as an infection with an A/E recombi-
nant. In fact, A/E recombinants from Central African Re-
public and Thailand were found to possess the same
pattern of mosaic structures by bootscanning (4, 8). It is
likely that CMR10 is also an A/E recombinant, because
we also obtained a XL PCR product (unpublished data).
The result of CMR317 (subtype B in the pol and subtype
A in the env) needed more careful consideration since it
might be the first case of a B/A recombinant. To exclude
the possibility that we missed detecting other sequences
in both regions, we used a different set of primers (Table
1) that are sensitive enough for detecting each subtype
in both regions. These primers were successfully used to
confirm four cases of mixed infection, as mentioned
above. However, only the sequence detected in the env
region was that of subtype A. In a similar manner, only
the sequence detected in the pol region was that of
subtype B. Based on these results, we consider that
cmr317 is not a case of mixed infection but a highly
probable case of a B/A recombinant.
The results of the present study help to answer the
following two important questions concerning mixed in-
fections: (i) what types of mixed infection can occur in
vivo? and (ii) what is the frequency of mixed infection?
Actually, we have found various types of mixed infection:
between different subtypes of HIV-1 group M, between
HIV-1 and HIV-2, and even between HIV-1 groups O and
M in four individuals. A case of triple infection (cmr61)
with HIV-1 group O and subtypes A and D (25) was
noteworthy. Our results also showed that the types of
mixed infection appeared to depend on the prevalence
rates of respective HIV-1 subtypes circulating in a certain
population, because three of four cases consisted of
combinations with HIV-1 subtype A, the most epidemic
subtype in Africa.
Regarding the frequency of mixed infections, it was
believed that the host’s immune response played a
role in protecting against superinfecting viruses, and
consequently mixed infection might be rare (6). How-
ever, the present study clearly indicated that various
types of mixed infection occurred at approximately
10% (4 to 6 of 43 cases), which is a rather high
frequency. Indeed, a significant proportion of individ-
FIG. 3—Continued
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uals may be co-infected (or superinfected) with vari-
ous HIV strains, where there is a greater variety of
HIV-1 subtypes circulating.
The high frequency of mixed infection appears to cor-
relate with the high incidence of recombinant viruses.
Recently, it was noted that 5 to 10% of HIV-1 strains that
have been at least partially sequenced consisted of
mosaic genomes (22, 6). In this study, three HIV-1s
(CMR10, CMR276, and CMR317) were suggested to pos-
sess intersubtype mosaic genomes. This incidence (3 of
43, 7%) is consistent with that in the database and may
be a consequence of the high frequency of mixed infec-
tion. Our findings that mixed infection with divergent
HIV-1 strains is not as rare as previously thought are
important, since such information provides a basis for
developing AIDS vaccines as well as for predicting the
global evolution of HIV in the future.
MATERIALS AND METHODS
Subjects
Study populations were recruited in selected Cam-
eroonian hospitals (Bertoua, Batouri, Yaounde´, Douala,
Akonolinga, Awae´, and Sangme´lima) in 1994 and 1995.
The subjects enrolled in this study were selected from
211 patients who were suspected of having sexually
transmitted disease (STD), tuberculosis (TB), and AIDS.
Patients were classified as being an asymptomatic car-
rier (AC), having AIDS-related complex (ARC), or having
full-blown AIDS. Basic sociodemographic information as
well as an assessment of risk factors for acquiring HIV
infection were collected for each patient. After obtaining
verbal informed consent, blood was collected in a cit-
rate-containing bag (ACD anticoagulant solution). A
syphilis serology was also performed and free treatment
was provided when necessary. Basic drugs (antifungal,
antibiotics etc.) were given when needed.
Serological tests
Sera were screened by a particle agglutination (PA)
test (Serodia-HIV, Fujirebio, Tokyo, Japan). All reactive
specimens were confirmed by a Western blotting (WB)
assay (New Lavblot HIV-1 and HIV-2; Sanofi Diagnostic
Pasteur, Marnes-la-Coquette, France). Dually reactive
sera were differentiated using a peptide-based assay
(Peptilav HIV-1 and HIV-2; Sanofi Diagnostic Pasteur) and
judged as HIV-1 or HIV-2 positive.
TABLE 1
Primers Used for Nested PCR
Primer Sequence (59–39) Location Usage
pol regiona
unipol5 TGGGTACCAGCACACAAAGGAATAGGAGGAAA 3434–3765 of HIV-1LAI Outer pair
unipol6 CCACAGCTGATCTCTGCCTTCTCTGTAATAGACC 4483–4516 of HIV-1LAI for HIV-1/2
HIV-1pol3 TAAAAGGAGAAGCCATGCATGGACAAGTAGA 3945–3975 of HIV-1LAI Outer pair
HIV-1pol4 TCACCTTTCCAGAGGAGCTTTGCTGGTCCTTTCC 4515–4548 of HIV-1LAI for HIV-1
HIV-2pol3 AAATGCAGAACTAGGCACTTGGCAAATGG 4218–4245 of HIV-2GH1 Outer pair
unipol6 CCACAGCTGATCTCTGCCTTCTCTGTAATAGACC 4727–4760 of HIV-2GH1 for HIV-2
unipol1 AGTGGATTCATAGAAGCAGAAGT 4052–4074 of HIV-1LAI Inner pair
unipol2 CCCCTATTCCTTCCCCTTCTTTTAAAA 4363–4388 of HIV-1LAI for HIV-1/2
env regionb
M5 CCAATTCCCATACATTATTGTGCCCCAGCTGG 6451–6482 of HIV-1LAI Outer pair
M10 CCAATTGTCCCTCATATCTCCTCCTCCAGG 7225–7254 of HIV-1LAI for group M
M7 GTCCAAAGGTATCCTTTGAGCCAATTCCCATAC 6431–6463 of HIV-1LAI Outer pair
M12 GGTGGGTGCTACTCCTAGTGGTTCAATTT 7286–7314 of HIV-1LAI for group M
O7 GAGCCCATTCCCATACACTATTGTGCTCC 6889–6917 of HIV-1MVP5180 Outer pair
O8 TTCTCCATATATCTTTCATGTCTCCCCCT 7692–7720 of HIV-1MVP5180 for group O
M3 GTCAGCACAGTACAATGIACACATGG 6541–6566 of HIV-1LAI Inner pair
M8 TCCTTGGATGGGAGGGGCATACATTGC 7114–7140 of HIV-1LAI for group M
O3 CACATGGCATCAAGCCAACAGTAAGTAC 7001–7028 in HIV-1MVP5180 Inner pair
O4 TAGGTTTCCTGGGATGGGAGGTGCATA 7582–7608 in HIV-1MVP5180 for group O
a Universal HIV-1/2 primers (unipol5 and unipol6) were used in the standard first round. In addition, we used HIV-1-specific primers (HIV-1pol3 and
HIV-1pol4) and HIV-2-specific primers (HIV-2pol3 and unipol6) in the first round.
b HIV-1 group M-specific primers (M5 and M10) were used in the standard first round. In cases of mixed infection or recombination, we also used
HIV-1 group M-specific primers (M7 and M12) in the first round.
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TABLE 2
Epidemiological and Clinical Information for Study Participants
Subject Age (years) Sexa
Virus
isolation
Disease
statusb
Blood
transfusion IDUc Year Serology
Genotype
pol env
cmr7 55 F Isolate ARC —d — 1994 HIV-1 A A
cmr90 34 M AC — — 1994 IDe A A
cmr100 16 F AC — — 1994 HIV-1 A A
cmr105 21 F AC — — 1994 HIV-1 A A
cmr116 28 F AC — — 1994 HIV-1 A A
cmr118 34 M Isolate AIDS — — 1994 HIV-1 A A
cmr142 24 M AC — — 1994 HIV-1 A A
cmr146 32 M AC — — 1994 HIV-1 A A
cmr153 35 M AIDS — — 1994 HIV-1 A A
cmr154 40 F AC — — 1994 HIV-1 A A
cmr157 49 M AC — — 1994 HIV-1 A A
cmr261 38 M Isolate AIDS — — 1994 HIV-1 A A
cmr273 NAf NA NA NA NA 1994 HIV-1 A A
cmr274 NA NA NA NA NA 1994 HIV-1 A A
cmr278 NA NA NA NA NA 1994 HIV-1 A A
cmr279 NA NA NA NA NA 1994 HIV-1 A A
cmr285 NA NA NA NA NA 1994 HIV-1 A A
cmr301 33 M Isolate ARC — — 1994 HIV-1 A A
cmr302 27 M Isolate ARC — — 1994 HIV-1 A A
cmr306 NA F Isolate AC — — 1994 HIV-1 A A
cmr308 NA M Isolate AIDS — — 1994 HIV-1 A A
cmr309 NA M Isolate ARC — — 1994 HIV-1 A A
cmr323 NA NA NA NA NA 1994 HIV-1 A A
cmr329 NA NA NA NA NA 1994 HIV-1 A A
cmr363 49 M ARC — — 1995 HIV-1 A A
cmr371 50 M AIDS — — 1995 HIV-1 A A
cmr413 NA F AC — — 1995 HIV-1 A A
cmr419 44 F ARC — — 1995 HIV-1 A A
cmr277 NA NA NA NA NA 1994 HIV-1 B B
cmr68 45 F AC — — 1994 HIV-1 D D
cmr370 NA NA AC — — 1995 HIV-1 D D
cmr158 34 M Isolate AIDS — — 1994 HIV-1 F F
cmr271 NA NA NA NA NA 1994 HIV-1 F F
cmr304 NA M Isolate ARC — — 1994 HIV-1 F F
cmr376 NA M ARC — — 1995 dual HIV O NA
cmr421 19 M AC — — 1995 HIV-1 O NA
cmr10 34 F AIDS — — 1994 HIV-1 A E
cmr276 NA NA NA NA NA 1994 HIV-1 A G
cmr317 NA NA NA NA NA 1994 HIV-1 B A
cmr281 NA NA NA NA NA 1994 HIV-1 ‘‘A, C’’g ‘‘A, C’’
cmr275 NA NA NA NA NA 1994 HIV-1 ‘‘C, F’’ ‘‘C, F’’
cmr106 25 F AC — — 1994 dual HIV ‘‘A, 2a’’h ‘‘A, ND’’i
cmr61 22 F ARC — — 1994 HIV-1 ‘‘O, A, D’’ ‘‘O, A, D’’
a M, male; F, female.
b AC, asymptomatic carrier; ARC, AIDS-related complex.
c IDU, injection drug user.
d —No history.
e ID, indeterminate.
f NA, information not available.
g ‘‘A, C’’, mixed-infection with HIV-1 subtypes A and C; the contents of mixed-infection are expressed likewise in the following specimens.
h 2a, HIV-2 subtype A.
i ND, not done.
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Virus isolation
Peripheral blood mononuclear cells (PBMCs) from
confirmed (or indeterminate) HIV-positive patients were
separated by Ficoll gradient sedimentation and coculti-
vated with virus-free human PBMCs or human T-lym-
phoid cell lines (Molt-4 clone 8 (15) or M8166 (5)). Cul-
tures were periodically checked by immunofluorescence
assay (IFA) for expression of viral antigens using autol-
ogous and reference anti-HIV-1 and/or -2 sera. Antigen-
positive cultures were subsequently examined for virus
production by measuring reverse transcriptase (RT) ac-
tivity in the supernatants as described (27). Regardless
of the results of virus isolation, primary uncultured PB-
MCs were analyzed for HIV by PCR.
PCR and DNA sequencing
Chromosomal DNA was extracted from PBMCs using
glass milk powder (Prep-A-Gene DNA purification kit;
Bio-Rad, Hercules, CA), and the following two regions of
proviral DNA were amplified by nested PCR. One region
(corresponding to 4075–4362 nt in HIV-1LAI) was part of
the pol open reading frame that encodes integrase. The
other region (corresponding to 6613–6999 nt in HIV-1LAI)
was part of the gp 120 gene of covering one-fourth of the
C2 region, the V3 domain, and the whole length of the C3
region. The primers used are listed in Table 1. PCR was
performed as previously described (23, 24). Purified PCR
products (339 bp long in the pol region and approxi-
mately 600 bp long in the env region) were subcloned
into the SmaI site of pUC119. DNA sequencing was
carried out by the dideoxy chain-termination method us-
ing an automated DNA sequencer (373A; Applied Bio-
systems, Foster City, CA). At least seven plasmid clones
were sequenced to obtain the consensus sequence.
Phylogenetic analysis
DNA sequences were aligned by the ODEN program
package at the National Institute of Genetics, Mishima,
Japan. Nucleotide substitutions were estimated by the six-
parameter method (9), and then the phylogenetic tree was
constructed by the neighbor-joining method, and its reliabil-
ity was estimated by 100 bootstrap replications (7).
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